ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,633Medicare Part D Prescriptions Filled, Including Refills

Rank: 295 out of 1383

$487K Total Retail Price of All Prescriptions

Rank: 372 out of 1383

476 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

27% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 6,357 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 486 273 S3 1 1
LISINOPRIL 419 261 2 3
LEVOTHYROXINE SODIUM 406 276 3 4
FUROSEMIDE 335 175 4 7
LOVASTATIN 294 157 5 22
AMLODIPINE BESYLATE 287 210 6 6
OMEPRAZOLE 254 178 7 5
METFORMIN HCL 249 173 8 8
HYDROCHLOROTHIAZIDE 205 114 9 10
POTASSIUM CHLORIDE 201 103 10 12
METOPROLOL TARTRATE 195 121 11 9
CARVEDILOL 195 147 11 24
GABAPENTIN 182 80 13 11
LOSARTAN POTASSIUM 175 106 14 23
WARFARIN SODIUM 153 120 15 13
SIMVASTATIN 150 116 16 2
NEXIUM 139 58 17 26
CLONIDINE HCL 130 64 18 44
MELOXICAM 129 92 19 20
SERTRALINE HCL 121 65 20 21
ZOLPIDEM TARTRATE 119 58 21 17
AZITHROMYCIN 113 68 22 41
CLOPIDOGREL 108 91 23 28
PREDNISONE 95 55 24 40
DOXYCYCLINE HYCLATE 94 52 25 94
RANITIDINE HCL 92 36 26 19
TRAZODONE HCL 92 54 26 36
PROMETHAZINE HCL 91 13 R 28 56
FLUTICASONE PROPIONATE 88 21 29 39
PLAVIX 84 72 30 43
ATORVASTATIN CALCIUM 83 68 31 18
TRAMADOL HCL 80 32 32 25
VENTOLIN HFA 77 56 33 93
CIPROFLOXACIN HCL 76 45 34 54
PROAIR HFA 76 24 34 42
CARISOPRODOL 75 19 R 36 76
PRAVASTATIN SODIUM 73 56 37 14
LANTUS 73 45 37 50
GLIMEPIRIDE 73 42 37 31
CYCLOBENZAPRINE HCL 71 36 R 40 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 56 41 27
BENAZEPRIL HCL 67 65 42 38
PANTOPRAZOLE SODIUM 66 28 43 32
TERAZOSIN HCL 65 53 44 111
VERAPAMIL ER 61 40 45 84
DIOVAN 60 50 46 58
ATENOLOL 59 43 47 16
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 25 48 89
LYRICA 56 32 49 72
FAMOTIDINE 56 50 49 61
SYMBICORT 55 40 51 166
ALENDRONATE SODIUM 55 49 51 37
CITALOPRAM HBR 54 18 53 15
CRESTOR 53 22 54 34
FLUOXETINE HCL 53 36 54 52
KLOR-CON 10 52 28 56 74
TRIAMTERENE-HCTZ 51 45 57 48
CYMBALTA 50 0 58 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.